Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00367003 · ClinicalTrials.gov registry record · NA

Deep Brain Stimulation for Treatment Resistant Depression

A NA study of Major Depressive Disorder, sponsored by Emory University.

Active
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT00367003 is a NA study of Major Depressive Disorder that is active but no longer recruiting, run by Emory University. The registered enrollment target is 37 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00367003, a NA study of Major Depressive Disorder, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the safety, efficacy and mechanism of action of subgenual cingulate (Cg25) deep brain stimulation (DBS) for major depression in patients who have not responded to prior antidepressant treatments. Participation in the study will continue for ten years or until the device receives FDA approval for depression. Forty (40) patients will be enrolled in this study.

Conditions Studied

Interventions

  • DEVICE Deep Brain Stimulation

Study Locations (1)

Georgia

  • Emory University School of Medicine - Atlanta

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2006-09
Est. Completion 2029-01
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00367003

The ClinicalTrials.gov registry entry for NCT00367003 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.

NCT00367003 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00367003 about?

NCT00367003 is a clinical study titled "Deep Brain Stimulation for Treatment Resistant Depression". The purpose of this study is to test the safety, efficacy and mechanism of action of subgenual cingulate (Cg25) deep brain stimulation (DBS) for major depression in patients who have not responded to prior antidepressant treatments. Participation in the study will continue for ten years or until the...

What is the current status of trial NCT00367003?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 37 participants. The study started on 2006-09. Estimated completion is 2029-01.

What conditions does trial NCT00367003 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT00367003?

The interventions under investigation include: Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00367003?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00367003 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.